Sino Biological Inc banner

Sino Biological Inc
SZSE:301047

Watchlist Manager
Sino Biological Inc Logo
Sino Biological Inc
SZSE:301047
Watchlist
Price: 72.58 CNY Market Closed
Market Cap: ¥8.8B

Sino Biological Inc's latest stock split occurred on Mar 30, 2022

The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.

Before the split, Sino Biological Inc traded at 364.01 per share. Afterward, the share price was about 179.3204.

The adjusted shares began trading on Mar 30, 2022. This was the only stock split in Sino Biological Inc's history.

Last Splits:
Mar 30, 2022
1-for-1
Pre-Split Price
177.8456 364.01
Post-Split Price
179.3204
Before
After
Last Splits:
Mar 30, 2022
1-for-1

Sino Biological Inc
Stock Splits History

Sino Biological Inc Stock Splits Timeline
Mar 30, 2022
Mar 30, 2022
Split 1-for-1
/1
Pre-Split Price
177.8456 364.01
Post-Split Price
179.3204
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 27, 2026
M
Mitsubishi Logisnext Co Ltd
TSE:7105
1-for-22962728
/22962728
1529 999999.9999 JPY N/A
Apr 27, 2026
Intsig Information Co Ltd
SSE:688615
1-for-1
x1
180.14 127.0214 CNY 128 128 CNY
Apr 27, 2026
Nousouken Corp
TSE:3541
1-for-550000
/550000
763 763 JPY N/A
Apr 27, 2026
F
Friendly Corp
TSE:8209
1-for-1355800
/1355800
312 999999.9999 JPY N/A
Apr 27, 2026
I
IA Inc
KOSDAQ:038880
1-for-10
/10
135 1350 KRW 1231 1231 KRW
Load More

Sino Biological Inc
Glance View

Market Cap
8.8B CNY
Industry
Biotechnology

Sino Biological Inc. emerged as a pivotal player in the life sciences sphere from its inception, carving a niche through its extensive portfolio of biological reagents, particularly recombinant proteins and antibodies. This Beijing-headquartered company swiftly gained acclaim by developing high-quality, cost-effective products that cater to the needs of researchers, pharmaceutical companies, and biotechnology firms worldwide. Its expansive catalog, boasting thousands of products, is meticulously curated to support research and development in areas such as immunology, cancer research, and infectious diseases. Sino Biological’s facility, equipped with state-of-the-art technology, combines automation with expert human oversight to ensure precision in production, fundamentally driving its reputation for reliability and innovation. At the heart of Sino Biological’s business model lies a commitment to accelerating the pace of biomedical research through its comprehensive suite of products and services. The company generates revenue by not only selling its own products but also by offering custom services, including protein production, antibody development, and assay development, tailored to meet specific client needs. By employing a business strategy that emphasizes collaboration and tailored solutions, Sino Biological successfully fosters long-term partnerships with its clients. This approach not only fortifies its foothold in the industry but also ensures a steady income stream as it plays a vital role in facilitating breakthroughs in medical research and development globally.

Intrinsic Value
53.37 CNY
Overvaluation 26%
Intrinsic Value
Price ¥72.58
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett